drugset / Trial / NCT01281007

Efficacy of Oral Famciclovir 125mg Comparing to Aciclovir 200 mg Treatment in Patients With Active Recurrent Genital Herpes

NCT01281007

Phase 3 Completed 150 enrolled EMS
RandomizedParallel-groupOpen-labelTreatment

Summary

Recurrent genital herpes is a commonly occurring sexually transmitted disease caused by herpes simplex virus (HSV). There are effective oral prescription antiviral medicines available to reduce the discomfort of symptoms, such as famciclovir and aciclovir. This is a phase III, multicenter, randomized, parallel-group study to compare the efficacy and safety of treatment with famciclovir (125 mg) versus aciclovir (200 mg) in patients with active recurrent genital herpes.

Timeline

Start
2012-07
Primary completion
2015-01
Completion
2015-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acyclovir Small molecule 200 mg Oral
Subject Famciclovir Small molecule 125 mg Oral

Indications